398 related articles for article (PubMed ID: 22365330)
1. Cellular senescence and cancer chemotherapy resistance.
Gordon RR; Nelson PS
Drug Resist Updat; 2012; 15(1-2):123-31. PubMed ID: 22365330
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in the development and treatment of cancer.
Saretzki G
Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
[TBL] [Abstract][Full Text] [Related]
3. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
4. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
5. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
6. Autophagy and PTEN in DNA damage-induced senescence.
Sharma A; Almasan A
Adv Cancer Res; 2021; 150():249-284. PubMed ID: 33858598
[TBL] [Abstract][Full Text] [Related]
7. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
[TBL] [Abstract][Full Text] [Related]
9. Cellular Senescence: The Sought or the Unwanted?
Sun Y; Coppé JP; Lam EW
Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
[TBL] [Abstract][Full Text] [Related]
10. Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
Peng S; Sen B; Mazumdar T; Byers LA; Diao L; Wang J; Tong P; Giri U; Heymach JV; Kadara HN; Johnson FM
Oncotarget; 2016 Jan; 7(1):565-79. PubMed ID: 26623721
[TBL] [Abstract][Full Text] [Related]
11. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
[TBL] [Abstract][Full Text] [Related]
12. Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer.
Francica P; Nisa L; Aebersold DM; Langer R; Bladt F; Blaukat A; Stroka D; Martínez MR; Zimmer Y; Medová M
Clin Cancer Res; 2016 Nov; 22(21):5322-5336. PubMed ID: 27185371
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-11-keto-β-boswellic acid triggers premature senescence via induction of DNA damage accompanied by impairment of DNA repair genes in hepatocellular carcinoma cells in vitro and in vivo.
Wang S; Wang H; Sun B; Li D; Wu J; Li J; Tian X; Qin C; Chang H; Liu Y
Fundam Clin Pharmacol; 2020 Feb; 34(1):65-76. PubMed ID: 31141202
[TBL] [Abstract][Full Text] [Related]
14. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
15. 4,5-Diphenyl-2-methyl picolinate induces cellular senescence by accumulating DNA damage and activating associated signaling pathways in gastric cancer.
Zhao Z; Shang D; Qiu L; Guo C; Li Y; Liu H; Yuan G; Tu Z
Life Sci; 2019 Dec; 238():116973. PubMed ID: 31639393
[TBL] [Abstract][Full Text] [Related]
16. Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.
Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Steelman LS; McCubrey JA
Oncotarget; 2011 Aug; 2(8):610-26. PubMed ID: 21881167
[TBL] [Abstract][Full Text] [Related]
17. Exploiting cellular senescence to treat cancer and circumvent drug resistance.
Yan Q; Wajapeyee N
Cancer Biol Ther; 2010 Feb; 9(3):166-75. PubMed ID: 20118655
[TBL] [Abstract][Full Text] [Related]
18. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.
Coudre C; Alani J; Ritchie W; Marsaud V; Sola B; Cahu J
Cell Cycle; 2016 Aug; 15(16):2174-2182. PubMed ID: 27340936
[TBL] [Abstract][Full Text] [Related]
20. The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells.
Mohiuddin M; Kasahara K
Cancer Genomics Proteomics; 2021; 18(5):661-673. PubMed ID: 34479918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
